3. Regulation of drugs containing nanoparticles
3.1 The origins of drug regulation
The idea of independent pre-market evaluation of medicines is a relatively recent one. It first appeared in various parts of the world around 1960 and, like many regulations, was unfortunately prompted by tragedies, such as that involving thalidomide in Europe. There is still no global drug regulation, but since 1990, awareness of a globalized market has led to the harmonization of regional regulations (Europe, USA and Japan) with the creation of the International Council for Harmonization (ICH). The ICH now brings together numerous regulatory authorities, as well as representatives of the pharmaceutical industry, the WHO (World Health Organization) and national observers from various countries. This organization brings together pharmacopoeias from...
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
Regulation of drugs containing nanoparticles
Benefit/risk balance of nanoparticle-based drugs
Article included in this offer
"Drugs and pharmaceuticals"
(
125 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
Bibliography
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
